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Abstract
Background: Non-compliance with medication is a major health problem. Cultural differences
may explain different compliance patterns. The size of the compliance burden and the impact of
socio-demographic and socio-economic status within and across countries in Europe have,
however, never been analysed in one survey. The aim of this study was to analyse 1) medical drug
compliance in different European countries with respect to socio-demographic and socio-
economic factors, and to examine 2) whether cross-national differences could be explained by
these factors.
Methods: A multi-country interview survey European Social Survey, Round 2 was conducted in
2004/05 comprising questions about compliance with last prescribed drug. Non-compliance was
classified as primary and secondary, depending whether the drug was purchased or not. Statistical
weighting allowed for adjustment for national differences in sample mechanisms. A multiple
imputation strategy was used to compensate for missing values. The analytical approach included
multivariate and multilevel analyses.
Results: The survey comprised 45,678 participants. Response rate was 62.5% (range 43.6–79.1%).
Reported compliance was generally high (82%) but the pattern of non-compliance showed large
variation between countries. Some 3.2% did not purchase the most recently prescribed medicine,
and 13.6% did not take the medicine as prescribed. Multiple regression analyses showed that each
variable had very different and in some cases opposite impact on compliance within countries. The
multilevel analysis showed that the variation between countries did not change significantly when
adjusted for increasing numbers of covariates.
Conclusion:  Reported compliance was generally high but showed wide variation between
countries. Cross-national differences could, however, not be explained by the socio-demographic
and socio-economic variables measured.
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Background
Non-compliance with medication is a major health prob-
lem worldwide and prevalent for all kinds of drugs and
degrees of diseases. Poor compliance may have a far
greater impact on the health of the population than any
improvement in specific medical treatments [1]. Further,
compliance differs substantially across countries [2,3].
Usually, the limit between good and poor compliance is
set at 80% [4]. Whether or not advice about drug treat-
ment is followed depends on various factors including
physician, patient, communicative, social and cultural cir-
cumstances. European societies are highly diverse with
regard to family structures, education, employment prac-
tices, ethnicity, religious beliefs, and also the structure of
healthcare systems. Hence, wide variation between coun-
tries in attitudes towards drug taking may be expected, i.e.
patient behaviour concerning compliance with prescribed
drugs may vary between countries due to cultural differ-
ences [2,3]. The impact of socio-economic status has been
divergently reported [5-9]. However, diverging outcomes
may be explained by methodological or contextual differ-
ences. This paper is based on the first large-scale multi-
country survey including information on drug use and
compliance as well as socio-demographic and socio-eco-
nomic factors.
The aim of the study was by way of a multi-level approach
to analyse 1) medical drug compliance in European coun-
tries with respect to socio-demographic and socio-eco-
nomic factors and to examine 2) whether cross-national
differences could be explained by socio-demographic and
socio-economic factors (citizenship, ethnic status, sex,
age, education, profession, household income).
Methods
We conducted a multi-country study based on data from
the European Social Survey, ESS round 2, 2004/2005
including 24 countries and comprising 73,090 individu-
als [10]. According to national options, participants were
sampled by means of telephone books, postcode address
files, population registers or social security register data.
In the sampling procedure it was ensured that regardless
of the method used for a specific country, the statistical
precision was the same for all countries. In each country
information was collected using a main and a supplemen-
tary questionnaire filled in through an hour-long face-to-
face interview including questions on use of medicine,
immigration, citizenship, socio-demographic and socio-
economic issues [11]. The ESS questionnaire was trans-
lated into the language of each of the participating coun-
tries by language experts, supported by the ESS
Translation Taskforce and further supervised by a Central
Coordinating Team [10].
Data are kept within and distributed by the Norwegian
Social Science Data Services (NSD) [12]. Data is openly
available at the homepage.
Information on compliance behavior related to question
D9 in the questionnaire: Please think back to the last time a
doctor prescribed you a medicine you had not had before.
Which statement on the card comes closest to what you did with
this prescription? 1: I didn't collect the medicine from the phar-
macy; 2: I collected the medicine but didn't use any of it; 3: I
used some or all of the medicine but not exactly as prescribed;
4: I used the medicine exactly as prescribed; 5: can't remember
last occasion. Individuals were categorized as compliant
(4th statement), primary non-compliant (1st) or secondary
non-compliant (2nd or 3rd statement). The independent
variables included: gender, age, education level (five levels
based on level of completed education), household
income (twelve groups), cohabitation (living with or
without a partner), ethnic minority (belonging or not
belonging to an ethnic minority group), and profession.
The latter was classified according to the occupation
standard ISCO 88, the official classification standard of
the International Labour Organization (ILO) [13]. To
compare professional groups across European countries,
individuals were further categorised into four groups
(Controller/Non-manual, Self-employed, Manual, and
Farming) according to a slight modification of the model
suggested by Leiulfsrud et al for use with the ESS data
[14,15].
Statistical analyses
As not all countries could include subjects with equal
probability, the data contains weights which correct for
this when included in the analysis. Further, the weights
allows for differences in population size between coun-
tries, such that even though country specific samples have
approximately similar sizes, larger countries contribute
more than smaller countries in analyses across countries
when weights are used [16]. To account for non-response
to individual items, a multiple imputation strategy [17]
was applied for all variables studied, i.e. both with the
respect to the compliance question and the explanatory
variables. Country was included as an additional explana-
tory variable in imputations. The imputation and subse-
quent analyses were conducted using the ice  and
micombine procedures available in Stata 9.2 [18]. The mul-
tiple imputation strategy is valid upon the Missing At Ran-
dom assumption, i.e., that the values missing can be
unbiasedly predicted from the remaining observed data. It
should be noted, that using the response variable as a pre-
dictor in the model for imputations, does not invalidate
subsequent analyses of the same outcome with respect to
the covariates of interest [19].BMC Public Health 2009, 9:145 http://www.biomedcentral.com/1471-2458/9/145
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To achieve a measure for household income meaningful
across countries we created a log-mean scale for income in
different countries, as this was found to yield a reasonable
linear relationship with compliance on a log-odds-scale.
Consequently, log-income was used as a linear covariate
in logistic regression analyses of compliance.
Chi square test followed by Fisher's Exact Test was used to
evaluate differences between categories. A multivariate
analysis was undertaken to adjust for potential confound-
ing of variables on each other. In order to assess the effect
of covariates on the variation of compliance between
countries, a multilevel analysis was made. A full-fledged
analysis with country-dependent random effects was
numerically intractable on available computers – except
for the most basic situation with only one country-
dependent random effect. Instead, we set up a two-step
fixed model based on logistic regression: First, a fixed
effect model was fitted via logistic regression for each
country independently. Relevant estimates of effects (on
the log-odds scale) from these models were then joined
together and their standard deviation was computed.
Confidence intervals for standard deviations were com-
puted using bootstrap methodology. This was done both
with and without relevant covariates, to allow for assess-
ing how much of the observed variation in compliance
between countries could be explained by adjusting for
observed covariates. Subsequently, we summarized the
variation in dependence of covariates between countries.
All covariates were centered at their mean to yield fair
comparisons of adjusted and unadjusted variations
between countries.
Stata 9.2 was used for all analyses.
Results
The mean response rate was 62.5% varying between
43.6% in France and 79.1% in Estonia. In total 45,678
participants from 24 countries were included ranging
from 579 in Iceland to 3,026 in the Czech Republic. A
total of 41,102 participants answered the compliance
questions. The 45,678 participants represented an effec-
tive (i.e. weighted) sample size of 37,718. Additional file
1 shows the distribution of the socio-demographic and
socio-economic variables within countries weighted with
respect to design and sampling differences. (Additional
file 2 further includes 95% confidence intervals for all
parameters).
The pattern of reported compliance showed large varia-
tion (Figure 1). Across Europe, non-compliance with lat-
est prescribed drug was 16.8%, varying from 6.4% in
Portugal to 24.9% in Luxemburg. Some 3.2% did not col-
lect the medicine at all (primary non-compliance) (0.6%
in the Netherlands to 8.5% in Norway), while 13.6%
(5.6% in Portugal to 21.6% in Luxemburg) did not take
the medicine as prescribed (secondary non-compliance).
7.1% did not remember last occasion, 1.4% never had a
drug prescribed, and 1.9% answered otherwise or did not
answer at all.
Additional file 3 shows the degree of reported compliance
according to socio-demographic and socio-economic cat-
egories. The multiple regression analysis including gen-
der, age, cohabitation, education, income, profession,
ethnic minority, and country (additional file 4) showed
no difference in reported compliance between males and
females but compliance increased with age. People living
with a partner were significantly more compliant than sin-
gles. People with an education longer than 12 years were
significantly less compliant than those with shorter educa-
tion but people living in households with higher incomes
were significantly more compliant. Manual workers and
ethnic minority groups were significantly less compliant
than the other groups. The effect of each variable varied
substantially between the countries. For example, the
female:male OR ranged from 0.86 to 1.52.
In the multilevel analysis the variation between countries
was expressed as the standard deviation (SD) i) without
correction, ii) with correction for gender and age, and iii)
with correction for all covariates. The SDs were 0.39
(CI95% 0.25–0.54), 0.39 (0.25–0.54) and 0.42 (0.23–
0.62). Similar numbers for more homogenous subgroups
of respondents are shown in additional file 5. Thus, the
variation in compliance between countries did not change
significantly even when adjusting for increasing numbers
of covariates.
Discussion
A relatively high level of reported compliance was
observed, but with substantial variation between the 24
European countries. The total, primary and secondary
non-compliance differed as did the association with
socio-demographic and socio-economic factors. Across
boundaries, however, no general association with these
social factors was found.
The questionnaire of round 2 of the European survey – in
contrast to round 1 -included questions specifically
designed to illustrate compliance issues. Although the
questions were not specifically designed for the present
study, we believe that they suffice to satisfy our compli-
ance definitions.
In the design phase of the survey, considerable effort was
used to minimise sampling bias to ensure that the
obtained sample – when weighted appropriately – was
representative of the source population studied. As the
questionnaire was an omnibus covering many differentBMC Public Health 2009, 9:145 http://www.biomedcentral.com/1471-2458/9/145
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aspects of life, non-participation cannot be directly related
to a specific subject area such as non-compliance,
although a subtle relation may exist due to underlying fac-
tors. In the analysis phase we further employed a multiple
imputation strategy to include subjects with partially
missing responses, and thus we have increased statistical
efficiency as no subjects have been excluded due to partial
non-response. The generally high compliance reported
may be an overestimate due to other kinds of bias, e.g.
recall or "honesty" bias, i.e. participants may have been
reluctant to report non-compliance. The willingness to
answer truthfully may further differ across countries. On
the other hand, compliance may have been underesti-
mated due to the rather strict definition: "I used the med-
icine exactly as prescribed". The definition was
furthermore based on the most recently prescribed drug
they "had not had before". This has most likely been a
drug for an acute condition, with which compliance is
known to be better than with chronic medication [20]. We
have, however, no reason to believe that this invalidates
our conclusions regarding between country comparisons.
Analyses of variables based on a large number of catego-
ries gathered in substantially different countries require
collapse of categories. Working with the ISCO 88 occupa-
tion standard we found a class scheme with four groups
appropriate. More categories would have made the model
infeasible as one or more would not have been repre-
sented in all countries. Fewer categories, on the other
hand, would have diminished the value of the variable.
Using a log scale for household income instead of the
actual figures made it possible to compare the impact of
income in different countries.
Compliance depends on a variety of factors including
indication, the drug, side effects, and drug regimen etc
[21]. Compliance with short antibiotic regimens has been
reported to approach 100% [22], whereas long-term com-
pliance with chronic medication has been reported to be
as low as 50% [23]. A Swedish study reported primary
non-compliance to be 2.4% but with three-fold variation
depending on substance [24]. We are not aware of any
other studies comparing compliance in a large number of
culturally diverse countries. However, cross-national stud-
ies comparing compliance in two areas/countries have
Total compliance and primary and secondary non-compliance in 24 European countries Figure 1
Total compliance and primary and secondary non-compliance in 24 European countries.
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been published [2,4] with observations of substantial dif-
ferences in compliance between regions. These studies are
methodologically different as they are based on prescrip-
tion claims data.
Across countries we found that compliance increased with
age, which may be due to the fact, that younger people are
less authoritarian and do not feel the same burden of sick-
ness. They are therefore not apt to follow medication as
strictly as older people. More elderly may, however be
affected by chronic diseases and be prone to polyphar-
macy known to decrease compliance [25,26]. Across
countries there may be unrecovered differences in the pat-
tern of chronic diseases or polypharmacy. Living with a
partner meant better compliance, perhaps because of a
more structured daily routine than among those living
alone. People with the shortest education were more com-
pliant than those with a longer one, suggesting that the
better educated people feel more responsible for their
own health and make decisions about discontinuing drug
treatment [27]. In contrast, higher income was associated
with better compliance, reflecting the simple fact that
wealthier people can better afford the drugs. However
unexplainably, manual workers seem less compliant than
more occupationally independent groups. Underuse of
prescribed drugs may be cost-related [28,29]. However, in
this survey we did not have information on drug cost or
specific reimbursement rules in the participating coun-
tries.
Conclusion
In conclusion, compliance was generally reported to be
high. There was a wide variation between countries. The
differences could not be explained by the socio-demo-
graphic and socio-economic variables investigated in this
study. Thus, other factors must contribute to the variation
to a large extent, e.g. differences in the availability of med-
ications between countries, additional factors, differences
in the prevalence of specific diseases or conditions, health
insurance systems, etc. This is a natural issue for further
research.
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(weighted counts) by total N and percentages distributed by country 
and socio-demographic and socio-economic variables (95% confidence 
intervals shown in additional file 2). This file shows the distribution of 
the socio-demographic and socio-economic variables within countries 
weighted with respect to design and sampling differences.




The European Social Survey, round 2, 2004/5. Participants (weighted 
counts) by total N and percentages including 95% confidence inter-
vals distributed by country and socio-demographic and socio-economic 
variables. In addition to the data presented in the additional file 1, this 
file further includes 95% confidence intervals for all parameters.




Level of compliance according to categories (percentages, odds ratios 
and 95% confidence intervals) in the European Social Survey, round 
2, 2004/5. This file shows the degree of reported compliance according to 
socio-demographic and socio-economic categories.




Odds ratios for compliance adjusted for all covariates including coun-
try (country of residence omitted in the table) in the European Social 
Survey, round 2, 2004/5. *Log odds for trend (income on log-scale with 
base 2). This file represents the multiple regression analysis of compliance 
including gender, age, cohabitation, education, income, profession, ethnic 
minority, and country.




The variation between countries expressed as standard deviation (SD 
(95% CI)) for all and for more homogenous subgroups of respondents. 
This file represents the analysis of the variation of compliance between 
countries, unadjusted as well as adjusted for various and all covariates.
Click here for file
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